Your browser doesn't support javascript.
loading
Health-related quality of life in parents and partners of people with type 1 diabetes: Development and validation of type 1 diabetes and life (T1DAL) measures.
Hilliard, Marisa E; Minard, Charles G; Marrero, David G; de Wit, Maartje; DuBose, Stephanie N; Verdejo, Alandra; Jaser, Sarah S; Kruger, Davida; Monzavi, Roshanak; Shah, Viral N; Wadwa, R Paul; Weinstock, Ruth S; Thompson, Debbe; Cao, Viena T; Anderson, Barbara J.
Afiliação
  • Hilliard ME; Department of Pediatrics.
  • Minard CG; Institute for Clinical and Translational Research.
  • Marrero DG; Indiana University School of Medicine.
  • de Wit M; Department of Medical Psychology.
  • DuBose SN; Jaeb Center for Health Research.
  • Verdejo A; Jaeb Center for Health Research.
  • Jaser SS; Department of Pediatrics.
  • Kruger D; Division of Endocrinology, Diabetes, Bone and Mineral Disorders.
  • Monzavi R; Center for Endocrinology, Diabetes and Metabolism.
  • Shah VN; Barbara Davis Center for Diabetes.
  • Wadwa RP; Barbara Davis Center for Diabetes.
  • Weinstock RS; Department of Medicine.
  • Thompson D; USDA/ARS Children's Nutrition Research Center.
  • Cao VT; Department of Pediatrics.
  • Anderson BJ; Department of Pediatrics.
Fam Syst Health ; 39(2): 234-247, 2021 06.
Article em En | MEDLINE | ID: mdl-33900103
INTRODUCTION: Despite the significant impact of type 1 diabetes (T1D) on family, few instruments are available to assess health-related quality of life (HRQOL) among family members of people with T1D. This study aimed to develop and evaluate the psychometric properties of new measures of diabetes-specific HRQOL for parents and partners of people with T1D. We report on the multistep development and validation process for the self-report Type 1 Diabetes and Life (T1DAL) measures, with versions for parents of youth age <8, 8-11, 12-17, and 18-25 years, and for partners of people age ≥18 years with T1D. METHOD: First, we conducted qualitative interviews (total parents/partners n = 38) to develop draft measures and piloted them (total n = 20). Next, we tested the measures' psychometric properties. Participants (total across versions n = 813) at six T1D Exchange Clinic Network sites completed the appropriate T1DAL measure and validated measures of related constructs. We then reduced each T1DAL measure to 20-30 items in length based on psychometric data and participant feedback. Eleven participants reviewed the final measures via cognitive debriefing. RESULTS: The T1DAL measures for parents and partners demonstrated good internal consistency (α = .80-.88) and test-retest reliability (r = .73-.86). Correlations with measures of general quality of life, generic and diabetes-specific HRQOL, and diabetes burden demonstrated construct validity. Factor analyses identified 3-4 subscales/measure. Participants reported being satisfied with the shortened measures, which took 5-10 minutes to complete. DISCUSSION: The new T1DAL measures for parents and partners of people with T1D are reliable, valid, and ready for use in research and clinical settings. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2021 Tipo de documento: Article